Aktien aus dem Gesundheitswesen
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4540 |  DYAI Dyadic International, Inc. - Common Stock | 0.42 USD | +2.44% | -10.64% | +2.44% | -60.00% | 15.30 M USD | ||
| 4542 |  HSCS HeartSciences Inc. - Common Stock | 3.18 USD | +5.30% | -2.45% | -18.46% | -4.22% | 15.26 M USD | ||
| 4543 |  TCRX TScan Therapeutics, Inc. - Common Stock | 0.24 USD | +14.29% | +4.35% | -29.41% | -90.32% | 15.24 M USD | ||
| 4548 |  BCDA BioCardia, Inc. - Common Stock | 0.97 USD | +4.30% | -8.49% | -22.40% | -16.38% | 14.68 M USD | ||
| 4550 |  FEMY Femasys Inc. - Common Stock | 1.74 USD | +11.54% | -17.14% | -32.03% | +135.14% | 14.57 M USD | ||
| 4554 |  IRIX IRIDEX Corporation - Common Stock | 0.82 USD | 0.00% | -10.87% | +30.16% | -21.90% | 14.40 M USD | ||
| 4557 |  TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.07 USD | +7.00% | -1.83% | -37.79% | -70.28% | 14.27 M USD | ||
| 4566 |  LPCN Lipocine Inc. - Common Stock | 1.68 USD | -0.59% | -10.64% | -22.22% | -42.07% | 13.85 M USD | ||
| 4569 |  KTTA Pasithea Therapeutics Corp. - Common Stock | 0.41 USD | 0.00% | -8.89% | -14.58% | -43.84% | 13.70 M USD | ||
| 4570 |  NCEL NewcelX Ltd. - Ordinary Shares | 2.85 USD | +9.20% | -5.63% | -13.64% | -43.90% | 13.67 M USD | ||
| 4574 |  ICU SeaStar Medical Holding Corporation - Common Stock | 3.06 USD | +1.66% | -14.29% | +5.15% | +24.39% | 13.48 M USD | ||
| 4577 |  HIND Vyome Holdings, Inc. - Common Stock | 1.91 USD | 0.00% | -5.91% | -2.55% | -63.27% | 13.41 M USD | ||
| 4580 |  GTBP GT Biopharma, Inc. - Common Stock | 7.36 USD | +18.52% | +23.49% | -5.64% | +982.35% | 13.28 M USD | ||
| 4581 |  ALLR Allarity Therapeutics, Inc. - Common stock | 0.83 USD | -4.60% | -17.00% | -26.55% | -41.13% | 13.21 M USD | ||
| 4591 |  RADX Radiopharm Theranostics Limited American Depositary Shares | 1.08 USD | -3.57% | +0.93% | -36.47% | -81.66% | 12.76 M USD | ||
| 4592 |  CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.46 USD | -2.13% | -6.12% | -20.69% | -68.49% | 12.63 M USD | ||
| 4593 |  BFRI Biofrontera Inc. - Common Stock | 0.85 USD | +2.41% | -8.60% | -30.89% | -10.53% | 12.62 M USD | ||
| 4605 |  ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 8.64 USD | +5.88% | -0.35% | +0.70% | +453.85% | 12.12 M USD | ||
| 4607 |  PLSM Pulsenmore Ltd. - Ordinary Shares | 1.85 USD | +1.65% | -0.54% | -24.18% | -79.10% | 12.03 M USD | ||
| 4608 |  ACTU Actuate Therapeutics, Inc. - Common stock | 0.50 USD | +16.28% | -21.88% | -51.92% | -87.75% | 12.01 M USD |
Nachrichten Aktien aus dem Gesundheitswesen
Organon präsentiert Daten aus seiner laufenden Phase-3-Studie des Intrauterinpessars MIUDELLA auf der Jahresversammlung 2026 der Society of Family Planning
Ironwood Pharmaceuticals ernennt Tammi Gaskins zur CEO, wirksam ab dem 1. Januar 2027
Eli Lilly erhält positive CHMP-Stellungnahme der EMA mit Empfehlung zur Marktzulassung von Foundayo zur Behandlung von Typ-2-Diabetes mellitus und zur Gewichtskontrolle
Needham bekräftigt Kaufempfehlung für Neurocrine Biosciences und hält am Kursziel von 204 US-Dollar fest
Tiziana Life Sciences beginnt mit der Dosierung des letzten Patienten in seiner klinischen Phase-2-Studie zur Bewertung von intranasalem Foralumab bei Patienten mit früher/leichter Alzheimer-Krankheit; Topline-Daten werden für Q1 2027 erwartet
Tango Therapeutics wird auf dem ESMO-Kongress 2026 aktualisierte Daten aus der Phase-1/2-Studie von Vopimetostat in Kombination mit Daraxonrasib oder Zoldonrasib bei Patienten mit MTAPdel/RASmut-metastasiertem PDAC und NSCLC vorstellen
Regeneron Pharma sagt, dass der CHMP der EMA eine positive Stellungnahme zur Empfehlung der Zulassung eines alternativen Dosierungsschemas für Libtayo in allen zugelassenen Indikationen angenommen hat
Gewinner Aktien aus dem Gesundheitswesen
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
Verlierer Aktien aus dem Gesundheitswesen
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |